Skip to main content

Events

What's new

The relationship between obesity and diabetes is complex, but the many relevant factors related to genetics, lifestyle, and the environment are becoming clearer. Hear expert opinions on these relationships, as well as insights on treatments and weight stigma from diaTribe’s Solvable Problems in Diabetes panel discussion. Continue Reading »

diaTribe is attending the 57th annual European Association for the Study of Diabetes (EASD) conference this week. Keep an eye out later this week for the biggest news and highlights from one of the largest gatherings of experts in the world this year. Continue Reading »

At our September Musings event, experts in diabetes technology gathered to discuss what the explosion of data means for people with diabetes, healthcare providers, and systems, and how it will continue to improve management and care.  Continue Reading »

One of the most powerful ways to change a person’s mind is to have a one-on-one conversation. By focusing on the power of storytelling, diaTribe encourages people to share their experiences as an effective tool to fight against stigma, stereotypes, and the harmful trap of the single story of diabetes. Continue Reading »

At the Milken Institute 2021 Future of Health Summit, leading experts in type 1 diabetes research and innovation discussed the path toward a cure, the latest in glucose monitoring technology, and the importance of screening for type 1 diabetes. Continue Reading »

At our second virtual Musings event of the year, we heard five experts discuss type 1 diabetes preventions, delays, and cures – including the importance of screening.  Continue Reading »

At the third virtual DiabetesMine D-Data ExChange, we learned about the latest in DIY automated insulin delivery and the newest in diabetes technology from smart insulin pen caps and minimally invasive continuous glucose monitors. Continue Reading »

Highlights from The diaTribe Foundation and TCOYD panel discussion at ADA 2021 include changing standards of care, continuous glucose monitoring, and the latest in diabetes drug development. Continue Reading »

Pages